The DOI matches its Crossref record; 211 of the 213 references it cites were found in a registry or an index.
Mechanisms and biomaterials in pH-responsive tumour targeted drug delivery: A review
Abstract
As the mainstay in the treatment of various cancers, chemotherapy plays a vital role, but still faces many challenges, such as poor tumour selectivity and multidrug resistance (MDR). Targeted drug delivery using nanotechnology has provided a new strategy for addressing the limitations of the conventional chemotherapy. In the last decade, the volume of research published in this area has increased tremendously, especially with functional nano drug delivery systems (nanocarriers). Coupling a specific stimuli-triggered drug release mechanism with these delivery systems is one of the most prevalent approaches for improving therapeutic outcomes. Among the various stimuli, pH triggered delivery is regarded as the most general strategy, targeting the acidic extracellular microenvironment and intracellular organelles of solid tumours. In this review, we discuss recent advances in the development of pH-sensitive nanocarriers for tumour-targeted drug delivery. The review focuses on the chemical design of pH-sensitive biomaterials, which are used to fabricate nanocarriers for extracellular and/or intracellular tumour site-specific drug release. The pH-responsive biomaterials bring forth conformational changes in these nanocarriers through various mechanisms such as protonation, charge reversal or cleavage of a chemical bond, facilitating tumour specific cell uptake or drug release. A greater understanding of these mechanisms will help to design more efficient drug delivery systems to address the challenges encountered in conventional chemotherapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Acidic pH caused protonation leads to hydrophilic-hydrophobic phase transition for the anionic polymers, and hydrophobic- hydrophilic phase transition for cationic polymers, inducing deformation of amphiphilic structures leading to drug release [136].”
From Recent Advances in Nanomicelles Delivery Systems. (2020) · cites this paper as [136]
In the citing paper
“Generally, two basic perceptions define the mechanism of the pH-responsive nanoparticles, such as the cleavage of chemical bonds and nanocarrier protonation.138”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [138]
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,521
On Respiratory Impairment in Cancer Cells
Warburg, O. H. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,472
(1989) · PubMed · Cited by 3,343
Thermo- and pH-responsive polymers in drug delivery☆
SCHMALJOHANN, D. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.020 · Cited by 3,023
Danhier, F., Féron, O., & Véronique Préat, A. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,891
A review of stimuli-responsive nanocarriers for drug and gene delivery
Ganta, S., Devalapally, H., Shahiwala, A., & Amiji, M. M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.017 · Cited by 2,198
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
WICKI, A. N., Witzigmann, D., Balasubramanian, V., & Huwyler, J. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.12.030 · Cited by 1,962
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
Feng, S.-S. (2006) · Nanomedicine · doi:10.2217/17435889.1.3.297 · Cited by 1,951
Lipid polymorphism and the functional roles of lipids in biological membranes
Cullis, P. R., & KRUIJFF, B. D. (1979) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(79)90012-1 · Cited by 1,865
Flagged first, then by citations
2 of the 213 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- Immordino, 2006, Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential, Int. J. Nanomedicine, 1, 297
- Liu, 2014, pH-Sensitive nano-systems for drug delivery in cancer therapy, Biotechnol. Adv., 32, 693, 10.1016/j.biotechadv.2013.11.009 · DOI · Paper page
- Sun, 2014, Cancer stem cell therapy using doxorubicin conjugated to gold nanoparticles via hydrazone bonds, Biomaterials, 35, 836, 10.1016/j.biomaterials.2013.10.011 · DOI
- Carmali, 2014, Chapter 13-polyacetals, 219
Cited by
Sorted by citations
Items 601–700 of 1,000
Kazemi, M., Emami, J., Hasanzadeh, F., Minaiyan, M., Mirian, M., Lavasanifar, A., & Mokhtari, M. (2020) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892815666201006124604 · Cited by 16
Drug delivery nanosystems targeted to hepatic ischemia and reperfusion injury
Ferreira-Silva, M., Faria‐Silva, C., Baptista, P. V., Fernandes, E. G. R., Fernandes, A. R., & Corvo, M. L. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00915-8 · Cited by 16
Bioresponsive nanomedicines based on dynamic covalent bonds
Xin, X., Zhang, Z., Zhang, X., Chen, J., Lin, X., Sun, P., & Liu, X. (2021) · Nanoscale · doi:10.1039/d1nr02836g · Cited by 16
Encapsulation of polyprodrugs enables an efficient and controlled release of dexamethasone
Li, M., Jiang, S., Haller, A., Wirsching, S., Fichter, M., Simon, J., Wagner, M., Mailänder, V., Gehring, S., Crespy, D., et al. (2021) · Nanoscale Horizons · doi:10.1039/d1nh00266j · Cited by 16
Chen, S., Wang, X., Lin, M., Hou, Y., Ding, M., Kong, D., Sun, H., Zhang, Q., Li, J., & Zhou, Q. (2021) · Applied Materials Today · doi:10.1016/j.apmt.2021.101258 · Cited by 16
Ding, G., Zhu, C., Wang, Q., Cao, H., Li, B.-C., Yang, P., Stauber, R. H., Nie, G., & Li, Z. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.02.001 · Cited by 17
Gao, T., Fu, S., Quan, X., Sun, J., Jiang, M., & Li, J. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s566173 · Cited by 17
“245,246 A representative paradigm involves core-shell nanoparticles loaded with Zebularine, JQ1, and CpG, surface-functionalized with carboxymethyl chitosan (CMCS).”
Urease-Based Biocatalytic Platforms―A Modern View of a Classic Enzyme with Applied Perspectives
Hussain, A., Rafeeq, H., Afsheen, N., Jabeen, Z., Bilal, M., & Iqbal, H. M. N. (2021) · Catalysis Letters · doi:10.1007/s10562-021-03647-z · Cited by 15
Nanodrugs Detonate Lysosome Bombs
Xiang, Y., Li, N., Liu, M., Chen, Q., Long, X., Yang, Y., Xiao, Z., Huang, J., Wang, X., Yang, Y., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.909504 · Cited by 15
“Second, the enhanced permeability and retention effect (EPR effect) (Kanamala et al., 2016) in tumors allows nanodrugs to achieve high tumor selectivity.”
BackgroundReceptor-Targeted Dual pH-Triggered Intracellular Protein Transfer
Lyu, M., Yazdi, M., Lin, Y., Höhn, M., Lächelt, U., & Wagner, E. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00476 · Cited by 15
Nanocarriers for delivery of taxanes: A review on physicochemical and biological aspects
Arruda, B. R., Mendes, M. G. A., de Freitas, P. G. C., Reis, A. V. F., Lima, T. S., Crisóstomo, L. C. C. F., Nogueira, K. A. B., Pessoa, C., Petrilli, R., & Eloy, J. O. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.104070 · Cited by 15
Research progress of stimulus-responsive antibacterial materials for bone infection
Wang, C., Xu, P., Li, X., Zheng, Y., & Song, Z. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1069932 · Cited by 15
“pH responsive carriers have been developed earlier in the field of tumor therapy, similar to tumor microenvironment (Kanamala et al., 2016).”
BackgroundMohammadinezhad, F., Talebi, A., Allahyartorkaman, M., Nahavandi, R., Vesal, M., & Khiyavi, A. A. (2023) · Asian Pacific Journal of Cancer Biology · doi:10.31557/apjcb.2023.8.2.155-159 · Cited by 15
“Breast cancer is one of many malignancies for which cisplatin is frequently used as a chemotherapeutic agent [11].”
BackgroundWang, Z., Li, Z., Shi, Y., & Zeng, L. (2023) · Regenerative Biomaterials · doi:10.1093/rb/rbad087 · Cited by 15
“TME-responsive liposomes [27, 28], polypeptides [29] and inorganic nanomaterials with disulfide bond [30] could cleave into small nanocomponents by endogenous substances, by which the drugs release was caused.”
BackgroundFunctional Integration of DNA and Peptide-Based Supramolecular Nanoassemblies for Cancer Therapy
Dong, Y., Guo, Y., Song, W., Nie, G., & Li, F. (2023) · Accounts of Materials Research · doi:10.1021/accountsmr.3c00112 · Cited by 15
Rad, A. R., Faramarzi, M., & Heydarinasab, A. (2024) · Materials Today Communications · doi:10.1016/j.mtcomm.2024.108447 · Cited by 15
Immunotherapies for locally aggressive cancers
Adams, S. C., Nambiar, A., Bressler, E. M., Raut, C. P., Colson, Y. L., Wong, W. W., & Grinstaff, M. W. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115331 · Cited by 15
pH-responsive carbohydrate polymer-based nanoparticles in cancer therapy
Zhao, N., Shi, Y., Liu, P., & Lv, C. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.141236 · Cited by 15
L-EGCG-Mn nanoparticles as a pH-sensitive MRI contrast agent
Li, J., Jiang, X., Shang, L., Li, Z., Yang, C., Luo, Y., Hu, D., Shen, Y., & Zhang, Z. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1862363 · Cited by 15
“pH environment, mainly caused by lactate, has been extensively proven to be a tumor-specific characteristic (Kanamala et al., 2016).”
BackgroundpH-Responsive ECM Coating on Ti Implants for Antibiosis in Reinfected Models
Li, K., Zhang, L., Li, J., Yang, X., Zhou, J., & Han, Y. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c01143 · Cited by 15
Zhao, Y., Liu, B., Lou, R., Qi, Y., He, M., Long, S., Feng, W., & Yan, H. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.212848 · Cited by 15
A concise review on bio-responsive polymers in targeted drug delivery system
Karati, D. (2022) · Polymer Bulletin · doi:10.1007/s00289-022-04424-7 · Cited by 15
Chountoulesi, M., Perinelli, D. R., Foryś, A., Chrysostomou, V., Kaminari, A., Bonacucina, G., Trzebicka, B., Pispas, S., & Demetzos, C. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122440 · Cited by 15
Katiyar, R. S., & Jha, P. K. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00151 · Cited by 15
Wu, M., Sheng, J., Xie, Q., Qi, Y., Zhao, Y., & Zhang, S. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.144357 · Cited by 14
Yazdani, S., Mozaffarian, M., Pazuki, G., & Hadidi, N. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103153 · Cited by 16
“These systems are designed to exploit unique characteristics of pathological sites, such as tumors or inflamed tissues, where specific internal triggers such as pH gradients, redox potential, or enzymatic activity are markedly distinct from normal tissues [33 – 35].”
Wang, J., Chen, M., Li, S., & Ye, R. D. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00188 · Cited by 15
Thin films of cross-linked polylactic acid as tailored platforms for controlled drug release
Krtouš, Z., Kousal, J., Sedlaříková, J., Rašková, Z., Kučerová, L., Krakovský, I., Kučera, J., Ali‐Ogly, S., Pleskunov, P., & Choukourov, A. (2021) · Surface and Coatings Technology · doi:10.1016/j.surfcoat.2021.127402 · Cited by 14
Ullah, S., Nawaz, A., Farid, A., Latif, M. S., Fareed, M., Ghazanfar, S., Galanakis, C. M., Alamri, A. S., Alhomrani, M., & Asdaq, S. M. B. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14071366 · Cited by 14
“To overcome these barriers, various pH-sensitive polymers have been investigated [7].”
BackgroundRecent Advances in Messenger Ribonucleic Acid (mRNA) Vaccines and Their Delivery Systems: A Review
Belay, W. Y., Nibret, G., & Aschale, Y. (2023) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s418314 · Cited by 16
Wei, X., Song, M., Jin, G., Jia, W., Wang, J., Liang, M., & Zou, L. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215488 · Cited by 14
Gong, Z., Peng, S., Cao, J., Tan, H., Zhao, H., & Bai, J. (2024) · Nanotechnology · doi:10.1088/1361-6528/ad170b · Cited by 14
Engineered oncolytic bacteria for malignant solid tumor treatment
Wang, M., Song, X., Liu, X., Ma, C., Ma, J., & Shi, L. (2024) · Interdisciplinary medicine · doi:10.1002/inmd.20240005 · Cited by 16
Atypical artificial cells: Novel biomimetic materials for combating cancer
Ren, Z., Wan, Q., Zhu, Y., Li, L., Wang, K., Zhao, F., Jiao, K., Tang, M., Tay, F. R., Wan, M., et al. (2024) · Interdisciplinary materials · doi:10.1002/idm2.12199 · Cited by 15
Costa, R. C., NAGAY, B. E., Villa, J. E. L., Sotomayor, M. D. P. T., Neres, L. C. D. S., Benso, B., Aguayo, S. D., Sacramento, C. M., Ruiz, K. G. S., Spada, F. P., et al. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202406640 · Cited by 14
Wang, X., Zhang, S., Wang, X., Zhou, L., Tang, Y., Xiao, Y., Zhang, Y. X., & Li, W. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124917 · Cited by 14
Koyra, N., Yu, H., Drummond, C. J., Zhai, J., & Dyett, B. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2518225 · Cited by 15
“…acidic conditions as their carboxyl groups undergo protonation, which alters the LNP structure and enhances drug release in the tumor environment [166,167 Remarkably, an increase in pH in a given MO-oleic acid system resulted in the deprotonation of oleic acid molecules, making the molecule…”
Galbis, E., de‐Paz, M. ‐., Iglesias, N., Lacroix, B., Alcudia, A., & Galbis, J. A. (2017) · European Polymer Journal · doi:10.1016/j.eurpolymj.2017.02.032 · Cited by 15
Zhao, D., Yi, X., Xu, J., Yuan, G., Zhuo, R., & Li, F. (2017) · Journal of Materials Chemistry B · doi:10.1039/c6tb03211g · Cited by 14
Transforming stealthy to sticky nanocarriers: a potential application for tumor therapy
Gafur, A., Kristi, N., Maruf, A., Wang, G., & Ye, Z. (2019) · Biomaterials Science · doi:10.1039/c9bm00724e · Cited by 14
Rózga‐Wijas, K., & Sierant, M. (2019) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2019.104332 · Cited by 14
Endosomal pH-Responsive Fe-Based Hyaluronate Nanoparticles for Doxorubicin Delivery
Bae, Y., Kim, Y., & Lee, E. S. (2021) · Molecules · doi:10.3390/molecules26123547 · Cited by 14
“acidic pH-responsive Fe-based hyaluronate nanoparticles using aHA-DMA, ferrous chloride tetrahydrate (FeCl2/4H2O) [5,9,12], and doxorubicin (DOX, as an antitumor drug model).”
BackgroundMethodWang, Z., Yao, J., Guan, Z., Wu, H., Cheng, H., Yan, G., & Tang, R. (2021) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2021.112052 · Cited by 14
Physiologically Responsive Polyurethanes for Tissue Repair and Regeneration
Liu, W., Li, S., Wang, B., Peng, P., & Gao, C. (2022) · Advanced NanoBiomed Research · doi:10.1002/anbr.202200061 · Cited by 14
Core/Shell Magnetic Nanoparticles for Biomedical Applications
El‐Gendy, A. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813904-2.00002-4 · Cited by 14
Hespel, L., Asmar, A. E., Morandi, G., Lecamp, L., Picton, L., & Burel, F. (2017) · Macromolecular Chemistry and Physics · doi:10.1002/macp.201700016 · Cited by 14
Delivering biomedicines with stimuli‑responsive biomaterials
Singh, H., Darban, Z., Ebrahimi, A., Wani, A. K., Bashir, S. M., Avcı, H., Shahabuddin, S., Veettil, R. M., Banat, F., & Hassan, S. (2026) · Communications Materials · doi:10.1038/s43246-026-01163-4 · Cited by 13
pH-Responsive Polymeric Micelle Dynamic Complexes for Selective Killing of Helicobacter pylori
Tan, J., Fang, Y., Yang, C. H., Tay, J., Tan, N., Balakrishnan, N., Chua, B. L., Zhao, Y., Chen, Y., Hedrick, J. L., et al. (2023) · Biomacromolecules · doi:10.1021/acs.biomac.2c01374 · Cited by 14
Cheng, C., Sun, Y.-T., Lee, A.-W., Huang, S.-Y., Fan, W.-L., Chiao, Y., Tsai, H., & Lai, J. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c00644 · Cited by 13
Zhao, J., Liu, Y., Sun, J., Zhu, H., Chen, Y. X., Dong, T., Sang, R., Gao, X., Yang, W., & Deng, Y. (2020) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2020.111217 · Cited by 13
Chemical Reactions Trigger Peptide Self‐Assembly in vivo for Tumor Therapy
Zeng, X., An, H., & Wang, H. (2021) · ChemMedChem · doi:10.1002/cmdc.202100254 · Cited by 13
Wei, D., Tong, Q., An, Q., Ma, X., Jiang, X. L., Li, X., & Zeng, Y. (2022) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2022.112408 · Cited by 13
A C5N2 Nanoparticle Based Direct Nucleus Delivery Platform for Synergistic Cancer Therapy
Chen, W., Liu, J., Wang, Y., Jiang, C., Yu, B., Sun, Z., & Lu, L. (2019) · Angewandte Chemie · doi:10.1002/ange.201900884 · Cited by 13
Chang, Z., Yang, Y., Zhao, B., Li, H., Guan, Y., Zhao, Y., Yuan, H., & Ni, C. (2022) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2022.119412 · Cited by 13
Li, X., Zhang, S., Chen, Y., Wang, S., Xu, Q., & Xu, J. (2022) · Nanoscale · doi:10.1039/d2nr01749k · Cited by 13
PEG and PEG-peptide based doxorubicin delivery systems containing hydrazone bond
Balci, B., & Top, A. (2018) · Journal of Polymer Research · doi:10.1007/s10965-018-1506-6 · Cited by 13
Development and Evaluation of Stimuli-Responsive Chimeric Nanostructures
Naziris, N., Pippa, Ν., Stellas, D., Chrysostomou, V., Pispas, S., Demetzos, C., Libera, M., & Trzebicka, B. (2018) · AAPS PharmSciTech · doi:10.1208/s12249-018-1112-2 · Cited by 13
Zhao, K., Cheng, G., Zhang, B., Li, D., Han, J., Chen, J., Wang, B., Li, M., Xiao, T., Le, A., et al. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.110171 · Cited by 13
Feng, R., Wang, W., Zhu, L., Xu, H., Chen, S., & Song, Z. (2020) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.34670 · Cited by 13
Gheybi, H., Sattari, S., Bodaghi, A., Soleimani, K., Dadkhah, A., & Adeli, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-101750-0.00005-2 · Cited by 14
Shiba, H., Nishio, M., Sawada, M., Tamaki, M., Michigami, M., Nakai, S., Nakase, I., Fujii, I., Matsumoto, A., & Kojima, C. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb01980e · Cited by 12
Gao, Y., Shelling, A. N., Nolan, E., Porter, D. J. T., Leung, E. Y., & Wu, Z. (2024) · Journal of Liposome Research · doi:10.1080/08982104.2024.2305866 · Cited by 12
“In particular, pH-sensitive liposomes (pSL) not only release payload within an acidic tumor environment, they also promote drug escape from the acidic endosome lumen into the cytoplasm to have its effect [22].”
BackgroundSelf-citationResponsive Microneedles for Diagnostic and Therapeutic Applications of Ocular Diseases
Mi, B., Mu, J., Ding, X., Guo, S., & Hua, X. (2025) · Small Methods · doi:10.1002/smtd.202402048 · Cited by 12
Stimuli-responsive peptide-based nanodrug delivery systems for tumor therapy
Zhou, L., Zhang, T., Zhang, L., Deng, Q.-Y., Xia, Z.-Y., Chen, S., Cheng, D., Qiao, Z., & Wang, H. (2025) · Chemical Communications · doi:10.1039/d5cc00950b · Cited by 15
Tu, W.-M., Huang, X.-C., Chen, Y., Luo, Y.-L., Liau, I., & Hsu, H. (2019) · Analytica Chimica Acta · doi:10.1016/j.aca.2019.10.019 · Cited by 12
pH-responsive chimeric liposomes: From nanotechnology to biological assessment
Naziris, N., Saitta, F., Chrysostomou, V., Libera, M., Trzebicka, B., Fessas, D., Pispas, S., & Demetzos, C. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118849 · Cited by 13
Wang, D., Zhang, N., Yang, T., Jing, X., & Meng, L. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.130108 · Cited by 12
Fu, S., Zhou, L., Zeng, P., & Fu, S. (2021) · Fibers and Polymers · doi:10.1007/s12221-021-0401-7 · Cited by 12
Targeting and functional effects of biomaterials-based nanoagents for acute pancreatitis treatment
Cai, Y., Cao, Q., Li, J., & Liu, T. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1122619 · Cited by 12
“, passive, active, and physical targeting (Russ and Wagner, 2007; Ivey et al., 2016; Kanamala et al., 2016).”
Drug delivery nanosystems—An introduction
Dhanasekaran, H. R., Sharma, C. P., & Haridoss, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-50922-0.00001-8 · Cited by 12
Nayak, R., Meerovich, I. G., & Dash, A. K. (2019) · AAPS PharmSciTech · doi:10.1208/s12249-019-1367-2 · Cited by 12
Kang, S., Park, G. H., Kim, S., Kim, J., Choi, Y., Huang, Y. Y. S., Lee, Y., & Choi, T. H. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201900247 · Cited by 12
Niu, D., Jiang, Y. J., He, J., Jia, X., Qin, L., Hao, J., Zhao, W., Dai, B., & Li, Y. (2019) · ACS Applied Bio Materials · doi:10.1021/acsabm.9b00759 · Cited by 12
Bindhya, K. P., Maheswari, P. U., & Begum, K. M. M. S. (2021) · Materials Chemistry and Physics · doi:10.1016/j.matchemphys.2021.125055 · Cited by 12
An efficient synthetic route for a soluble silsesquioxane-daunorubicin conjugate
Rózga‐Wijas, K., & Michalski, A. (2016) · European Polymer Journal · doi:10.1016/j.eurpolymj.2016.09.058 · Cited by 12
Yilmaz, A. S., Pepe, A., Latifi, N., Sawyer, W. G., & Dunne, M. R. (2025) · Materials & Design · doi:10.1016/j.matdes.2025.115318 · Cited by 11
Fernandes, D. A. (2023) · Journal of Nanoparticle Research · doi:10.1007/s11051-023-05807-1 · Cited by 12
Recent advances in the development of poly(ester amide)s-based carriers for drug delivery
Xie, R., Li, J., Zhao, M., & Wu, F. (2024) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2024.102123 · Cited by 11
“The commonly used chemical bonds include hydrazones, Schiff bases, cis - maleic acid monoamides, and acetals (Kanamala et al., 2016).”
BackgroundKhan, A., & Sahu, N. K. (2021) · New Journal of Chemistry · doi:10.1039/d1nj03968g · Cited by 11
Huang, Y., Xu, Z., Wei, Y., Han, S., Cai, X., & Chen, D. (2022) · AAPS PharmSciTech · doi:10.1208/s12249-022-02254-4 · Cited by 11
“PEI is widely used in gene delivery systems to swell lysosomes and promote the lysosome escape of nucleic acid drugs (34, 37).”
BackgroundGhalehkhondabi, V., Fazlali, A., & Soleymani, M. (2023) · Materials Today Chemistry · doi:10.1016/j.mtchem.2023.101780 · Cited by 11
Tailoring Biomaterials Ameliorate Inflammatory Bone Loss
Cheng, S., Wang, K., Zhou, L., Sun, Z., & Zhang, L. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202304021 · Cited by 11
Oral delivery of self-assembling bioactive peptides to target gastrointestinal tract disease
Petit, N., Dyer, J. M., Clerens, S., Gerrard, J. A., & Domigan, L. J. (2020) · Food & Function · doi:10.1039/d0fo01801e · Cited by 11
Lü, X. Q., Cheng, H., Xu, Q., & Tan, X. (2021) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2020.4085 · Cited by 11
“31,32 36–38 To simulate the pH environment in the tumor tissues, the authors also investigated the in vivo drug release of liposomes in lower pH PBS buffer.”
Stimuli-Responsive MXene Nanomaterials for Advanced Antitumor Drug Delivery Systems
Deng, P., Ling, Z., Fang, F., Ruan, J., Yang, C., Hu, R., Zhou, J., & Xiong, P. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s552112 · Cited by 10
Xu, W., Yang, R., Xue, Y., Chen, Y., Liu, S., Zhang, S., Wang, Y., Liu, Y., & Zhang, H. (2024) · Aggregate · doi:10.1002/agt2.648 · Cited by 10
Targeting the lung tumour stroma: harnessing nanoparticles for effective therapeutic interventions
Zhang, S., & Wang, H. (2024) · Journal of drug targeting · doi:10.1080/1061186x.2024.2410462 · Cited by 10
“Nanodrugs that target cAiX has shown promising results in preclinical studies. in addition, targeting some molecules such as vegF or other growth factors can be proposed for remodelling tumour stroma [46].”
Hu, X., Wang, Y., Wang, R., Pu, Y., Jin, R., Nie, Y., & Shuai, X. (2025) · Nature Communications · doi:10.1038/s41467-024-55727-4 · Cited by 10
Harnessing nature: plant-derived nanocarriers for targeted drug delivery in cancer therapy
Alum, E. U., Nwuruku, O. A., Ugwu, O. P.-C., Uti, D. E., Alum, B. N., & Edwin, N. (2025) · Phytomedicine Plus · doi:10.1016/j.phyplu.2025.100828 · Cited by 10
Wang, P., Guo, S., Sun, M., Wei, G., & Chen, C. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c03002 · Cited by 10
Smart responsive biomaterials for spatiotemporal modulation of functional tissue repair
He, X., Han, Z., Ruan, Y., Wang, Z., Liao, B., Li, X., Tan, J., Han, X., Shen, J., & Bai, D. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102063 · Cited by 14
Nanocomposite liposomes for pH-controlled porphyrin release into human prostate cancer cells
Fuentes, G. V., Doucet, E. N., Abraham, A., Rodgers, N. K., Alonso, F., Euceda, N., Quinones, M. H., Riascos, P. A., Pierre, K., Sarker, N. H., et al. (2020) · RSC Advances · doi:10.1039/d0ra00846j · Cited by 10
Pérez-Hernández, M., Cuscó, C., Benítez-García, C., Bonelli, J., Nuevo-Fonoll, M., Soriano, A., Martínez‐García, D., Arias, A., García‐Valverde, M., Segura, M. F., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9050508 · Cited by 10
“Several researches have reported that differences in pH between tumor and healthy tissue can be exploited to promote targeted anticancer therapy [12].”
BackgroundLi, X., Yu, W., Yang, J., Chen, Y., Qian, X., Wang, J., Wang, Y., & Ji, J. (2022) · Biomaterials Science · doi:10.1039/d2bm01275h · Cited by 10
Qi, Q., Zhang, H., Liu, M., Qi, S., Huo, Z., Ma, Y., Zhang, Z., Lu, Y., Qi, X., Han, S., et al. (2023) · Cancer Nanotechnology · doi:10.1186/s12645-023-00179-6 · Cited by 10
“Thus, the established hollow mesoporous NiFe2O4 nanospheres can be employed as outstanding candidates for pH-responsive drug delivery system, which can avoid the burst release of loaded anticancer drugs from drug delivery system during blood circulation while enhance the intracellular drug release inside tumor cells (…”
BackgroundZhang, M., Li, D., Shan, P., Lian, X., Qi, Y., Du, K., Ma, G., Cai, L., Li, Z., & Li, Z. (2023) · Polymer Chemistry · doi:10.1039/d3py00586k · Cited by 10
Carvalho, S. G., dos Santos, A. M., Silvestre, A. L. P., Tavares, A. G., Chorilli, M., & Gremião, M. P. D. (2023) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2263360 · Cited by 10
“…due to their known properties, such as biocompatibility, bioavailability, and approval by the Food and Drug Administration (FDA), in addition to specific properties of the polymers (e.g. mucoadhesiveness, degradability by natural microbiota, resistance capacity under certain pH conditions) [16–18].”
Wang, C., Wang, J., Chen, X., Zheng, X., Xie, Z., Chen, L., & Chen, X. (2016) · Macromolecular Bioscience · doi:10.1002/mabi.201600227 · Cited by 10
Whang, C., Lee, H. K., Kundu, S., Murthy, S. N., & Jo, S. (2018) · Journal of Applied Polymer Science · doi:10.1002/app.46552 · Cited by 10
Dual stimuli-responsive saccharide core based nanocarrier for efficient Birc5-shRNA delivery
Chen, H., Ma, Y., Lan, H., Zhao, Y., Zhi, D., Cui, S., Du, J., Zhang, Z., Zhen, Y., & Zhang, S. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb01683f · Cited by 10
Metadata
- Authors
- Kanamala, M., Wilson, W. R., Yang, M., Palmer, B. D., & Wu, Z.
- Affiliations
- University of Auckland (NZ)
- Corresponding author
- Wu, Zimei
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2016-04
- Volume
- 85
- Pages
- 152-167
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2288119981
- Cited by
- 1,004
- References
- 213
- Citations by year
- 2026: 65 · 2025: 96 · 2024: 78 · 2023: 85 · 2022: 99 · 2021: 117 · 2020: 129 · 2019: 113 · 2018: 108 · 2017: 77 · 2016: 37
- FWCI
- 5.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biomaterials (publishedVersion)
- PubMed (publishedVersion)
- ResearchSpace (University of Auckland) (submittedVersion)
- Funders
- Royal Society of New Zealand (UOA1201)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Keywords
- pH-responsive nanocarriers, tumour-targeted drug delivery, stimuli-responsive drug release, intracellular drug release, protonation, charge reversal, bond cleavage, tumor selectivity, multidrug resistance, chemotherapy
- MeSH terms
- Animals, Biocompatible Materials, Clinical Trials as Topic, Disease Models, Animal, Humans, Hydrogen-Ion Concentration, Neoplasms, Drug Delivery Systems, Nanotechnology, Nanostructures, Drug Liberation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review